Snorenz Marketers Agree to Settle FTC Charges

Share this article:
Med Gen Inc., Boca Raton, FL, the company that produces Snorenz, a snore-treatment spray, and Tru-Vantage International LLC, Niles, IL, the DRTV producer responsible for the Snorenz campaign, have agreed to settle Federal Trade Commission charges that the companies did not have adequate substantiation to back up their claims about the efficacy of the product.

The FTC alleged that the companies' claims that Snorenz is an effective treatment for snoring and sleep apnea, a potentially life-threatening breathing disorder during sleep, are unsubstantiated. Under the consent agreements, the companies will be required to have scientific evidence to substantiate representations that Snorenz or any other food, drug or dietary supplement reduces or eliminates snoring or the symptoms of sleep apnea. Both companies also must include a warning about sleep apnea in ads for snoring remedies that have not been shown to be effective in treating the disorder.

The warning must state that the product is not intended to treat sleep apnea. It also must detail the symptoms of the disorder and its consequences and must note that people with sleep apnea should consult a doctor.

Share this article:
You must be a registered member of Direct Marketing News to post a comment.

Sign up to our newsletters

Follow us on Twitter @dmnews

Latest Jobs:

More in News

Day Two at DMA2014

Day Two at DMA2014

It was awards day in San Diego, with Teradata's Lisa Arthur being named Marketer of the Year, and Google Japan being feted for its direct mail prowess.

Today's Forecast: Chilly With a 10 Percent Lift in Parka Sales

Today's Forecast: Chilly With a 10 Percent Lift ...

The Weather Company launches a website offering marketers free advice on how to take advantage of shifts in the weather.

DMA 2014 Kicks Off Under New Management

DMA 2014 Kicks Off Under New Management

Thomas Benton and Jane Berzan will preside over an event indicative of an association serving a wider array of industry segments.